Personalized repetitive transcranial magnetic stimulation (PrTMS®) for post-traumatic stress disorder (PTSD) in military combat veterans
The article explores the use of **personalized repetitive transcranial magnetic stimulation (PrTMS)** for treating **post-traumatic stress disorder (PTSD)** in military combat veterans. 
The study involved 185 veterans and aimed to address PTSD symptoms by improving brain **default mode network (DMN)** activity, as PTSD is linked to disrupted DMN activity. The PrTMS 
treatment protocol used **EEG-based guidance** to optimize symptom resolution by adjusting stimulation parameters based on the brain's **alpha oscillations**.

Key findings:
- Veterans who received **4-6 weeks** of PrTMS showed significant clinical improvements, particularly in **cortical alpha activity**. More than **50% of participants** experienced full 
symptom resolution.
- PrTMS involves **stimulation of multiple brain regions**, with adjustments to **stimulation frequency** during treatment to target DMN disruptions.
- PrTMS demonstrated **improvements in PTSD, anxiety, and depression scores**, with reduced PTSD symptoms sustained for the duration of treatment.

The study concludes that PrTMS is a promising therapy for PTSD and suggests further **sham-controlled trials** to validate these findings.